These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Synthesis, In Vitro α-Glucosidase Inhibitory Activity and Molecular Docking Studies of Novel Benzothiazole-Triazole Derivatives. Gong Z, Peng Y, Qiu J, Cao A, Wang G, Peng Z. Molecules; 2017 Sep 15; 22(9):. PubMed ID: 28914795 [Abstract] [Full Text] [Related]
4. Tyramine Derivatives as Potent Therapeutics for Type 2 Diabetes: Synthesis and In Vitro Inhibition of α-Glucosidase Enzyme. Bashir MA, Javaid K, Shaikh M, Choudhary MI, Siddiqui H. Med Chem; 2020 Sep 15; 16(8):1124-1135. PubMed ID: 32003674 [Abstract] [Full Text] [Related]
5. Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies. Asgari MS, Mohammadi-Khanaposhtani M, Kiani M, Ranjbar PR, Zabihi E, Pourbagher R, Rahimi R, Faramarzi MA, Biglar M, Larijani B, Mahdavi M, Hamedifar H, Hajimiri MH. Bioorg Chem; 2019 Nov 15; 92():103206. PubMed ID: 31445191 [Abstract] [Full Text] [Related]
6. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose. Cardullo N, Floresta G, Rescifina A, Muccilli V, Tringali C. Bioorg Chem; 2021 Dec 15; 117():105458. PubMed ID: 34736132 [Abstract] [Full Text] [Related]
7. Novel Coumarin Containing Dithiocarbamate Derivatives as Potent α-Glucosidase Inhibitors for Management of Type 2 Diabetes. Mollazadeh M, Mohammadi-Khanaposhtani M, Valizadeh Y, Zonouzi A, Faramarzi MA, Kiani M, Biglar M, Larijani B, Hamedifar H, Mahdavi M, Hajimiri MH. Med Chem; 2021 Dec 15; 17(3):264-272. PubMed ID: 32851964 [Abstract] [Full Text] [Related]
9. Exploring the Dual Inhibitory Activity of Novel Anthranilic Acid Derivatives towards α-Glucosidase and Glycogen Phosphorylase Antidiabetic Targets: Design, In Vitro Enzyme Assay, and Docking Studies. Ihmaid S. Molecules; 2018 May 29; 23(6):. PubMed ID: 29844263 [Abstract] [Full Text] [Related]
11. Indane-1,3-diones: As Potential and Selective α-glucosidase Inhibitors, their Synthesis, in vitro and in silico Studies. Mukhtar A, Shah S, Kanwal, Hameed S, Khan KM, Khan SU, Zaib S, Iqbal J, Perveen S. Med Chem; 2021 May 29; 17(8):887-902. PubMed ID: 32851965 [Abstract] [Full Text] [Related]
12. Inhibitory activity evaluation and mechanistic studies of tetracyclic oxindole derivatives as α-glucosidase inhibitors. Sun H, Zhang Y, Ding W, Zhao X, Song X, Wang D, Li Y, Han K, Yang Y, Ma Y, Wang R, Wang D, Yu P. Eur J Med Chem; 2016 Nov 10; 123():365-378. PubMed ID: 27487567 [Abstract] [Full Text] [Related]
13. Facile synthesis and in silico studies of benzothiazole-linked hydroxypyrazolones targeting α-amylase and α-glucosidase. Punia R, Mor S, Khatri M, Kumar D, Das PP, Jindal DK, Kumar A, Selvaraj P, Kumar R, Mohil R, Jakhar K. Future Med Chem; 2024 Nov 10; 16(10):999-1027. PubMed ID: 38910576 [Abstract] [Full Text] [Related]
15. Synthesis of novel inhibitors of α-glucosidase based on the benzothiazole skeleton containing benzohydrazide moiety and their molecular docking studies. Taha M, Ismail NH, Lalani S, Fatmi MQ, Atia-Tul-Wahab, Siddiqui S, Khan KM, Imran S, Choudhary MI. Eur J Med Chem; 2015 Mar 06; 92():387-400. PubMed ID: 25585009 [Abstract] [Full Text] [Related]
17. Synthesis of indole derivatives as diabetics II inhibitors and enzymatic kinetics study of α-glucosidase and α-amylase along with their in-silico study. Taha M, Alrashedy AS, Almandil NB, Iqbal N, Anouar EH, Nawaz M, Uddin N, Chigurupati S, Wadood A, Rahim F, Das S, Venugopal V, Nawaz F, Khan KM. Int J Biol Macromol; 2021 Nov 01; 190():301-318. PubMed ID: 34481854 [Abstract] [Full Text] [Related]